Long Term Buy Call For Aurobindo Pharma

by khalid on 15/12/2010 · 2 comments

Stock Broking firm Karvy has given ‘Buy’ call on Aurobindo Pharma stock.

Current Market Price: Rs 1,262 on 14th Dec 2010
Target Price: Rs 1,645
Recommended By: Karvy Stock Broking

Stock Analysis :-

One of the largest API manufacturers in Asia, Aurobindo Pharma has commercialised over hundred APIs. Aurobindo has benefited from its shift from generics to value-added generics segment. Keeping the prices of the medicines at reasonable levels, shrinking FCCBs, staying at better position compared to its peers in terms of relative valuations, geting permissions to semi-sinthetic pencilin injections etc are some of the positive growth drivers for the company. Aurobindo has favorable agreements with Astrogenika and Pfizer and because of this it is expected to post good growth in revenues from the sales of generics in developing countries. It is expected to post a growth of 21% in revenues in the next year.

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

{ 2 comments… read them below or add one }

Nifty Tips December 15, 2010

Thanks For Sharing Sir

Reply

khalid December 15, 2010

you are welcome !

Reply

Previous post:

Next post: